A Maxwell Biosciences company

World leaders in peptoid design, research, and scale-up.

World's largest peptoid scaleup·#1 in peptoid R&D·Most advanced FDA peptoid drug program

End-to-end peptoid services for every kind of peptoid program — industrial, cosmetics, biotech, pharma, and beyond. From milligram exploration through GMP-inspected commercial supply, backed by ISO-certified manufacturing.

OOOR₁R₂R₃R₄NNNNN-SUBSTITUTED GLYCINE BACKBONE[ —N(R)—CH₂—C(=O)— ]ₙ
GMP
ISO 9001:2015
ISO 14001:2015
ISO 45001:2018
Sustainable Supply Chain Partner

01 — Why peptoids

A different molecular class. Built to scale.


Proteolytic stability

They survive where peptides don't.

N-substituted glycine backbones resist enzymatic degradation, opening routes peptides can't take.

IP whitespace

The chemistry is open and patentable.

A young modality with broad freedom-to-operate and a clear path to composition-of-matter protection.

Scale-ready

Submonomer synthesis, kilo-friendly.

Solid-phase and solution-phase routes both proven at gram-to-kilo scale in our reactor train.

02 — Capabilities

Process development and manufacturing — under one roof.


Process development

Route scouting to GMP-ready process.

  • Submonomer and PEG-coupling routes
  • Hastelloy / Inconel reactor compatibility
  • Analytical method development
  • Tech transfer documentation
Process details

Site & manufacturing

0.5 – 3 kL reactor train.

  • Three independent suites
  • Hydrogenation, inert atmosphere
  • 10 – 200 L kilo lab, low-temp to −80 °C
  • GMP-released material in ≤ 10 days
Facility details

Let's discuss your peptoid program.

Tell us where you are. We'll send back the right path to scale, the right experts, and the right paperwork.